NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Bio-Synthesis, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bio-Synthesis, Inc. Launches Peptide Library Generation Software - Bio-Synthesis has launched a new software intended to help with epitope identification and sequence optimization by using six powerful peptide libraries
Bio-Synthesis, Inc. Launches Peptide Library Generation Software

 

NewswireTODAY - /newswire/ - Lewisville, TX, United States, 2009/09/02 - Bio-Synthesis has launched a new software intended to help with epitope identification and sequence optimization by using six powerful peptide libraries.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Long established custom biomedical manufacturer, Bio-Synthesis, Inc., has launched the Peptide Library Generation Tools Software, a versatile platform complete with six powerful screening tools, each designed to help with epitope identification and sequence optimization to best fit the customer’s current/future applications. The tools include Overlapping Peptide Library, Alanine Scanning Library, Positional Library, Truncation Library, Random Library and Scrambled Library.

Each library has a different ability to assist and evaluate sequences based on the researchers specific needs. The overlapping library breaks down the original protein or peptide into fragments of equal length which allows the researcher to see which segments of the original protein or peptide yield the highest activity. The alanine scanning library is extremely useful in identifying which amino acids are essential to the peptide’s function by indicating the level of importance associated with each replaced amino acid.

The positional library is used when a position or positions in a peptide sequence are each replaced with different amino acids in order to determine the preferred amino acid residues at these positions. The truncation library is extremely useful for determining the minimum length required for optimum peptide activity. The goal of the random library protocol is to substitute randomly selected amino acids with a mixture of all 20 amino acids. The scrambled library is used to examine all possible combinations of the same amino acids from the original sequence.

As technology advances, screening tools such as these libraries prove to be invaluable to research, with each library having its own ability to quickly and efficiently examine and screen a sequence for epitope identification and sequence verification. The sequences generated through the Peptide Library Generation Tools Software can then be passed to Bio-Synthesis, Inc. for custom synthesis, a feature adding to the comprehensive approach to support the growth of more efficient, cost-effective, and focused research.

About Bio-Synthesis, Inc.
Bio-Synthesis, Inc. (biosyn.com), headquartered in Lewisville, Texas, is a leading biomedical manufacturer of custom peptide synthesis, custom antibodies, Custom PNA Synthesis, custom DNA, RNA synthesis, HLA/DNA typing, organic synthesis and a diverse number of bimolecular products for the biomedical/life science community worldwide since 1984. Their staff of highly experienced and qualified chemists, biologists and immunologists has reliably and consistently provided products and services to large pharmaceuticals and universities across the country that meet the most demanding requirements for quality, turnaround and expert technical support.

For more information, please call 1-800-227-0627.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Bio-Synthesis, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Bio-Synthesis, Inc. Launches Peptide Library Generation Software

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Angela Ragan - BioSyn.com 
972-420-8505 biosyn[.]biosyn.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bio-Synthesis, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bio-Synthesis, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition
Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment
Ono Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory
SCHOTT Pharma Launches EVERIC® Lyo & Amber Vials for Light-sensitive ADCs
Arbitration Tribunal Upholds Ipsen’s Termination of R&D Agreement with Galderma
New Data Reinforces Ipsen’s Commitment to Bringing Solutions and Addressing Care Gaps in Neurological Diseases At TOXINS
Opdivo® Intravenous Infusion Approved in Taiwan in Combination with Yervoy® for the Treatment of Adult Patients
U.S. FDA Grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in First Line Unfit Acute Myeloid Leukemia
Additional Approval of Combination Therapy with BRAFTOVI® Capsule, a BRAF Inhibitor, for the Indication of Colorectal Cancer in South Korea
BostonGene Recognized by Frost & Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions
Ipsen Expands Early Development Pipeline with Simcere Zaiming’s Innovative Antibody Drug Conjugate
Ipsen Update on Phase II FALKON Trial in Patients with Ultra-rare Bone Disease, Fibrodysplasia Ossificans Progressiva (FOP)

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  BookKeepXperts, LLC DBA SnapTax





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)